These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multi-Targeting DKK1 and LRP6 Prevents Bone Loss and Improves Fracture Resistance in Multiple Myeloma. Simic MK, Mohanty ST, Xiao Y, Cheng TL, Taylor VE, Charlat O, Croucher PI, McDonald MM. J Bone Miner Res; 2023 Jun; 38(6):814-828. PubMed ID: 36987921 [Abstract] [Full Text] [Related]
4. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. Witcher PC, Miner SE, Horan DJ, Bullock WA, Lim KE, Kang KS, Adaniya AL, Ross RD, Loots GG, Robling AG. JCI Insight; 2018 Jun 07; 3(11):. PubMed ID: 29875318 [Abstract] [Full Text] [Related]
5. Sclerostin antibody promotes bone formation through the Wnt/β-catenin signaling pathway in femoral trochlear after patellar instability. Xu C, Ji G, Chen X, Yan L, Liang T, Liu J, Wang F. Connect Tissue Res; 2023 Mar 07; 64(2):148-160. PubMed ID: 36379907 [Abstract] [Full Text] [Related]
6. Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice. Choi RB, Hoggatt AM, Horan DJ, Rogers EZ, Loots GG, Robling AG. J Bone Miner Res; 2023 May 07; 38(5):765-774. PubMed ID: 36891756 [Abstract] [Full Text] [Related]
7. Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates. Florio M, Kostenuik PJ, Stolina M, Asuncion FJ, Grisanti M, Ke HZ, Ominsky MS. J Bone Joint Surg Am; 2023 Aug 02; 105(15):1145-1155. PubMed ID: 37159527 [Abstract] [Full Text] [Related]
9. Mechanically Driven Counter-Regulation of Cortical Bone Formation in Response to Sclerostin-Neutralizing Antibodies. Gerbaix M, Ammann P, Ferrari S. J Bone Miner Res; 2021 Feb 02; 36(2):385-399. PubMed ID: 33049076 [Abstract] [Full Text] [Related]
10. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin. Sato AY, Cregor M, Delgado-Calle J, Condon KW, Allen MR, Peacock M, Plotkin LI, Bellido T. J Bone Miner Res; 2016 Oct 02; 31(10):1791-1802. PubMed ID: 27163932 [Abstract] [Full Text] [Related]
11. Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study. Vazquez-Villegas ML, Rodriguez-Jimenez NA, Contreras-Haro B, Vasquez-Jimenez JC, Perez-Guerrero EE, Moran-Moguel MC, Sánchez-Rodríguez EN, Villagómez-Vega A, Nuño-Arana I, Becerra-Alvarado IN, Rubio-Arellano ED, Nava-Valdivia CA, Ponce-Guarneros JM, Fajardo-Robledo NS, Nava-Zavala AH, Gonzalez-Lopez L, Saldaña-Cruz AM. Genet Test Mol Biomarkers; 2021 Mar 02; 25(3):211-217. PubMed ID: 33734895 [Abstract] [Full Text] [Related]
12. Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists. Holdsworth G, Greenslade K, Jose J, Stencel Z, Kirby H, Moore A, Ke HZ, Robinson MK. Bone; 2018 Feb 02; 107():93-103. PubMed ID: 29129759 [Abstract] [Full Text] [Related]
13. Sclerostin Protects Against Vascular Calcification Development in Mice. De Maré A, Opdebeeck B, Neven E, D'Haese PC, Verhulst A. J Bone Miner Res; 2022 Apr 02; 37(4):687-699. PubMed ID: 35038187 [Abstract] [Full Text] [Related]
14. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo. Niziolek PJ, MacDonald BT, Kedlaya R, Zhang M, Bellido T, He X, Warman ML, Robling AG. J Bone Miner Res; 2015 Oct 02; 30(10):1822-30. PubMed ID: 25808845 [Abstract] [Full Text] [Related]
15. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis. Jiao Z, Chai H, Wang S, Sun C, Huang Q, Xu W. J Mol Med (Berl); 2023 May 02; 101(5):607-620. PubMed ID: 37121919 [Abstract] [Full Text] [Related]
16. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women. Lim Y, Kim CH, Lee SY, Kim H, Ahn SH, Lee SH, Koh JM, Rhee Y, Baek KH, Min YK, Kim DY, Kim BJ, Kang MI. Calcif Tissue Int; 2016 Oct 02; 99(4):350-9. PubMed ID: 27289555 [Abstract] [Full Text] [Related]
17. Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats. Nioi P, Taylor S, Hu R, Pacheco E, He YD, Hamadeh H, Paszty C, Pyrah I, Ominsky MS, Boyce RW. J Bone Miner Res; 2015 Aug 02; 30(8):1457-67. PubMed ID: 25678055 [Abstract] [Full Text] [Related]
18. Disparate effects of sclerostin deletion on alveolar bone and cellular cementum in mice. Phanrungsuwan A, Chavez MB, Eltilib LA, Kolli TN, Mohamed FF, Tan MH, Salmon CR, Nociti FH, Foster BL. J Periodontol; 2024 Jul 16. PubMed ID: 39012429 [Abstract] [Full Text] [Related]
19. Activation of Wnt Signaling by Mechanical Loading Is Impaired in the Bone of Old Mice. Holguin N, Brodt MD, Silva MJ. J Bone Miner Res; 2016 Dec 16; 31(12):2215-2226. PubMed ID: 27357062 [Abstract] [Full Text] [Related]
20. Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration. Lim KE, Bullock WA, Horan DJ, Williams BO, Warman ML, Robling AG. Bone; 2021 Feb 16; 143():115708. PubMed ID: 33164872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]